Online Learning
13th Annual Meeting
Awakening Sleep Science:
Exploring Novel Dimensions of Sleep Medicine and Anesthesia
On-Demand
OUR PODCASTS ARE NOW AVAILABLE!
For SASM Members
- Exclusive content not available in the general marketplace
- Focused research data presented by industry experts
- Speaker notes and presentation files
- Earn CME
For Non-Members
- Exclusive content not available in the general marketplace
- Focused research data presented by industry experts
- Speaker notes and presentation files
- Earn CME
To access this content, simply login to your SASM account and click on the “Online Learning” button.
Society of Anesthesia and Sleep Medicine
2023 Society of Anesthesia and Sleep Medicine
Annual Meeting Enduring Material
Date of CE Release: December 1, 2023
Date of CE Expiration: November 30, 2024
Location: Online
Acknowledgment of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgment of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must listen to each self-directed audio recording while following along with the visual slides and complete an evaluation form to receive a certificate of completion. Your chosen sessions must be viewed in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Anesthesia and Sleep Medicine. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME) Credit Designation
Amedco LLC designates this enduring material for a maximum of 4.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
PAs may claim a maximum of 4.00 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. 4.00 hours.
Objectives – After Attending This Program You Should Be Able To
- Explain how sleep disorders in the general population greatly impact peri-operative and hospital outcomes.
- Describe the links between sleep disorders and opioid use, mood disorders including depression, and PACU outcomes.
- Discuss the society’s newly published consensus guidelines on diagnosing and managing sleep apnea during pregnancy.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
| First Name | Last Name | Commercial Interest:Relationship, |
|---|---|---|
| Joanne | Buckley | NA |
| Robson | Capasso | Invicta Medical:Scientific/Medical Advisory Board Member,Cryosa:Consultant,Bryte LLC:Scientific/Medical Advisory Board Member |
| Jennifer | Dominguez | NA |
| Stacy | Edwards | NA |
| Andrew | Krystal | Janssen Pharmaceuticals, Axsome Pharmaceutics, Attune, Harmony, Neurocrine Biosciences, Reveal Biosensors, The Ray and Dagmar Dolby Family Fund, and the National Institutes of Health:Research Grant Overall Principal Investigator,Axsome Therapeutics, Big Health, Eisai, Evecxia, Harmony Biosciences, Idorsia, Janssen Pharmaceuticals, Jazz Pharmaceuticals, Millenium Pharmaceuticals, Merck, Neurocrine Biosciences, Neurawell, Perni:Scientific/Medical Advisory Board Member,Neurawell, Big Health:Private Stock Shareholder |
| Edward | Mariano | NA |
| Sheryl | Morgan | NA |
| Kimmo | Murto | Janssen Pharmaceuticals Inc.:Research Grant Site Principal Investigator,Pfizer Pharmaceutical Company:Research Grant Site Principal Investigator |
| Olubukola | Nafiu | NA |
| Erika | Obispo | NA |
| Satya Krishna | Ramachandran | Fresenius Kabi:Research Grant Site Principal Investigator |
| Vidya | Raman | NDS Kalstars:Owner,Opus Influunt:Owner,face2 face:Other |
| Mandeep | Singh | NA |
| Toby | Weingarten | Medtronic:Consultant,Merck:Consultant,Takeda Pharmaceuticals :Consultant,Enalare Therapeutics Inc.:Consultant,Trevena, Inc.:Consultant |
| Christine | Won | NA |